| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,664 |
24,344 |
$1.41M |
| 20553 |
|
17,611 |
13,820 |
$649K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,979 |
15,548 |
$632K |
| 64483 |
|
4,533 |
3,527 |
$472K |
| 64635 |
|
1,795 |
1,412 |
$238K |
| 64484 |
|
4,103 |
3,200 |
$197K |
| 64493 |
|
2,083 |
1,622 |
$169K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,333 |
2,238 |
$138K |
| 64636 |
|
1,778 |
1,408 |
$135K |
| 20611 |
|
2,079 |
1,256 |
$125K |
| 64495 |
|
2,091 |
1,588 |
$99K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
584 |
547 |
$97K |
| 64494 |
|
2,040 |
1,610 |
$93K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
720 |
639 |
$90K |
| 62321 |
|
1,004 |
801 |
$79K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,119 |
544 |
$34K |
| 76881 |
|
339 |
303 |
$30K |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
60 |
25 |
$29K |
| 97164 |
|
900 |
403 |
$28K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,118 |
544 |
$20K |
| 64490 |
|
206 |
166 |
$20K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,120 |
544 |
$19K |
| 64633 |
|
107 |
94 |
$16K |
| 64491 |
|
219 |
179 |
$12K |
| 64492 |
|
195 |
146 |
$11K |
| 97162 |
|
206 |
188 |
$11K |
| 64634 |
|
104 |
94 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
230 |
189 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12,523 |
10,108 |
$5K |
| J3490 |
Unclassified drugs |
1,108 |
819 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
58 |
58 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,039 |
772 |
$4K |
| 99000 |
|
986 |
939 |
$1K |
| A4930 |
Gloves, sterile, per pair |
2,558 |
1,495 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
35 |
32 |
$835.67 |
| 99490 |
Ccm add 20min |
103 |
99 |
$371.43 |
| 96138 |
|
29 |
24 |
$322.60 |
| G2058 |
Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). |
34 |
34 |
$82.38 |
| A4215 |
Needle, sterile, any size, each |
2,966 |
1,779 |
$57.72 |
| A4248 |
Chlorhexidine containing antiseptic, 1 ml |
534 |
288 |
$39.04 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
9,894 |
6,992 |
$7.78 |
| 3008F |
|
2,317 |
1,779 |
$0.00 |
| 99070 |
|
491 |
253 |
$0.00 |
| A4550 |
Surgical trays |
850 |
495 |
$0.00 |
| 0521F |
|
52 |
29 |
$0.00 |